Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

Abroad (travel likely)RecruitingPHASE1

Conditions

Chronic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Quotient Sciences Sea View, Miami, Florida, United States
Contact: Study coordinator (Daniela Perez) · daniela.perez@quotientsciences.com · +1 305 644 9903
Contact: Principal Investigator (Juliet Vento)
Novartis Investigative Site, Berlin, Germany

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Anemia · Iron Deficiencies · Chronic Kidney Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Melbourne, Australia

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia · Chronic Kidney Disease Requiring Chronic Dialysis · End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Chula Vista, United States

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

Chronic Kidney Disease and Hypertension

Abroad (travel likely)RecruitingPHASE2

Surprise, United States · Hollywood, United States

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

Healthy Volunteers · Chronic Kidney Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Herston, Australia · Morayfield, Australia